PB2126: R-CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY
PB2126：R-CPOP 作为一线治疗方案，用于治疗左心室射血分数显著降低或蒽环类药物诱发心脏毒性风险高的弥漫性大B细胞淋巴瘤患者
期刊:Prostate Cancer and Prostatic Diseases
影响因子:5.8
doi:10.1038/s41391-023-00682-2
Ohlmann, Carsten-Henning; Jäschke, Michelle; Jaehnig, Peter; Krege, Susanne; Gschwend, Jürgen; Rexer, Heidrun; Junker, Kerstin; Zillmann, Roger; Rüssel, Christoph; Hellmis, Eva; Suttmann, Henrik; Janssen, Martin; Marin, Jan; Hübner, Andreas; Mathers, Michael; Gleißner, Jochen; Scheffler, Michael; Feyerabend, Susan; Telle, Jens; Klier, Jörg; Stöckle, Michael; Schwaner, Ingo; Hebart, Holger; Christoph, Losem; Thomas, Wolff; Burkard, Schmidt; Rossi, Davide; Caroline, Lehmann; Julia, Benzel; Johannes, Huelsenbeck; Petra, Pichler; Čuřík, Nikola; Laznicka, Adam; Polivkova, Vaclava; Křížková, Jitka; Semerak, Pavel; Pokorna, Eva; Suchankova, Pavla; Burda, Pavel; Hochhaus, Andreas; Machová Poláková, Kateřina; Seelisch, Jennifer; Kaste, Sue C; Kelly, Kara M; Kurch, Lars; Link, Michael P; Mauz-Koerholz, Christine; Mccarten, Kathleen; Punnett, Angela; Stroevesandt, Dietrich; Flerlage, Jamie E; Welslau, M; Kubuschok, B; Topaly, J; Otremba, B; Wolff, T; Bryn, G; Lorenz, K; Strüßmann, T; Trepel, M; Illerhaus, G; Pelz, H; Scholz, C; Duyster, J; Marks, R
